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264a Monday, March 4, 2019and participates in a salt-bridge between the switch I and switch II nucleotide
binding regions. We observed very minimal actin-activated ATPase activity for
the mutant compared to WT (2-fold compared to 100-fold activation, respec-
tively), while the basal ATPase was unchanged. R243H bound to actin in an
ATP-dependent manner based on actin-cosedimentation assays. We also
observed no actin-sliding by R243H in the in vitro motility assay. In the mixed
motility assay, low ratios (%50%) of R243H did not change or only slightly
decreased sliding velocities. At higher ratios of R243H (R50%) the velocity
decreased dramatically. We speculate that at low ratios of R243H/WT the
mutant myosin may cooperatively activate the actin thin filaments to allow
more opportunity for WT myosin heads to bind actin without slowing short-
ening velocity, which would correlate with HCM. At higher ratios of R243/
WT, the inhibitory action of R243Hmay dominate and slowmuscle shortening,
which would correlate with DCM.
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Single amino acid mutations to the cardiac thin filament have been shown to
cause genetic cardiomyopathies, a serious and sometimes deadly heart disorder.
Experimental groups have extensively studied many of these mutations in an
attempt to uncover the link between genotype and phenotype, but critical
atomic level details cannot be determined by these methods. To address this
gap, molecular dynamics (MD) simulations are utilized to model and study
the changes in conformation and dynamics imposed by these single point mu-
tations. The goal of this research is to move beyond identifying the effects mu-
tations have on the cardiac thin filament, and to determine a set of guidelines to
predict the clinical effects unstudied mutations will have on individuals. A set
of twenty different clinically determined amino acid mutations located in car-
diac troponin T and tropomyosin were chosen for analysis, and MD simulations
were performed using the fully atomistic cardiac thin filament previously
created by our group. From the simulations, conformation changes imposed
by the mutation, both local and distant to the site of mutation, were computed.
Steered molecular dynamics along with Jarzynski’s equality were utilized to
determine the changes in the free energy barrier of calcium binding and disso-
ciation due to mutation. Coupling the changes in conformation and calcium dy-
namics data together, subsets of mutations were created to begin the process of
determining guidelines for mutational predictions.
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Advanced materials, able to work as integrated actuators for the treatment of
muscle injuries, could combine rapid and long-lasting intervention, which is
the main goal in regenerative medicine. Among them, Liquid Crystalline Elas-
tomers (LCEs) are biocompatible polymers able to reversibly deform in
response to a given stimulus by generating movement. Once stimulated,
LCEs can mimic muscle force production. However, so far their application
in biology was limited by the slow response times and the reduced possibility
to modulate tension levels during activation. Thanks to a screening of different
monomeric formulations, a palette of biocompatible LCEs is prepared and pre-
cisely characterized in isometric conditions in terms of passive and active me-
chanical properties, showing improved muscle-like characteristic. Light
responsive LCEs stimulated with increasing laser powers, develop progres-
sively increasing active tensions with fast kinetics of activation and relaxation.
Tension levels and contraction time course can be modulate to reproduce twitch
contractions of cardiac samples from patients affected by specific diseases. As a
proof of concept, a LCE-based device able to develop concentric pressure, as in
cardiac chambers, was demonstrated opening for their use in the preparation of
contraction assist devices.1303-Pos
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Mutations in the human beta-cardiac myosin gene (MYH7) are responsible for
a large number of hypertrophic (HCM) and dilated (DCM) cardiomyopathies.
Omecamtiv mecarbil (OM) is a small molecule drug that induces allosteric
changes in beta-cardiac myosin activity and is in clinical trials for treatment
of systolic heart failure. OM binds in a narrow cleft adjacent to the SH1 helix,
relay helix, and converter domain of beta-cardiac myosin and interacts with res-
idues involved in linking changes in the nucleotide pocket to rotation of the
lever arm, known as the ‘coupling region’. Cardiomyopathy mutations
R712L and E497D disrupt a salt bridge between R712 and E497 that is centered
in the OM binding pocket and plays a role in coupling the relay helix to a small
beta-sheet of the converter domain. In the present study, we have characterized
the effect of the mutations and OM on the unloaded shortening velocity of
R712L and E497D beta-cardiac HMM mutants. The R712L mutation causes
a 5-fold slowing of motility, and increases the IC50 of OM binding to 30
mM from 0.1 mM for the WT cHMM. OM also restores the velocity of
R712L cHMM to 75% of WT cHMM velocity. On the other hand, the
E497D mutation has little effect on the velocity, but increases the IC50 of
OM to 4.5 mM. OM inhibits the velocity of E497D cHMM but only by 2.5-
fold compared to over 25-fold for WT cHMM. In conclusion, the dramatic ef-
fect on motility (R712L) and impact on the IC50 of OM (R712L and E497D)
suggest a central role of this buried salt bridge in coupling the nucleotide state
to rotation of the converter domain.
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Detyrosinated microtubules (dTyr MTs) buckle and bear load during myocyte
contraction providing a viscoelastic resistance to myocyte shortening. The
proliferation of dTyr MTs observed in heart failure increases myocyte visco-
elasticity but the pathological consequences on myocyte and myocardial func-
tion remain to be quantitatively assessed. To determine whether suppressing
dTyr MTs will reduce viscoelasticity and improve contractile dynamics pro-
portional to the severity of disease, we utilize parallel genetic and pharmaceu-
tical approaches to suppress MT dTyr in freshly isolated human
cardiomyocytes and myocardial strips and measure active and passive me-
chanical properties. Compared to myocytes isolated from non-failing human
hearts, suppression of dTyr MTs reduces viscoelasticity and increases un-
loaded shortening to a greater degree in failing cardiomyocytes. Manipulation
of dTyr MT levels does not significantly impact excitation-contraction
coupling and de novo mathematical modelling demonstrates that increased
contractile dynamics can be attributed to the experimentally measured
decrease in viscoelasticity. Preliminary results in myocardial strips from
failing hearts display greater viscoelasticity than non-failing myocardium,
with depolymerization of MTs in failing myocardium partially restoring pas-
sive mechanical properties. The results indicate that dTyr microtubules
constrain myocyte contractile dynamics in heart failure. Moreover, the micro-
tubules’ impact in regulating myocardial mechanical properties at rates
consistent with diastolic filling is evident in the presence of an intact extracel-
lular matrix.
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In hearts with dilated cardiomyopathy (DCM), the ventricular walls become
thin and weak, causing systolic dysfunction, and interventions to prevent the
